Hepion Pharmaceuticals, Inc. of RED BANK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2014-02-14. The offering totals $3.2M, of which $3.2M was reported sold. Industry: Biotechnology.
Showing 25 of 34 people.
| Name | Role | Location |
|---|---|---|
| Bernard F Denoyer | Director | New York, NY |
| Christopher P McGuigan | Director | New York, NY |
| Bernard F Denoyer | Executive Officer | New York, NY |
| Gary S Jacob | Executive Officer | New York, NY |
| Sireesh Appajosyula | Related Person | Red Bank, NJ |
| Gary Stetz | Related Person | Red Bank, NJ |
| Vincent LoPriore | Related Person | Red Bank, NJ |
| Robert Foster | Director | Waverly, OH |
| Robert Foster | Executive Officer | Waverly, OH |
| James Sapirstein | Director | Cincinnati, OH |
| James Sapirstein | Executive Officer | Cincinnati, OH |
| Kaouthar P Lbiati | Director | Edison, NJ |
| John Cavan | Executive Officer | Edison, NJ |
| Michael P Purcell | Director | Edison, NJ |
| Timothy P Block | Director | Edison, NJ |
| Anand Reddi | Director | Edison, NJ |
| Petrus P Wijngaard | Director | Edison, NJ |
| Gary S Jacobs | Director | Edison, NJ |
| Arnold P Lippa | Director | Edison, NJ |
| Todd Hobbs | Executive Officer | Edison, NJ |
| Gary Jacob | Director | San Diego, CA |
| John Brancaccio | Director | San Diego, CA |
| Thomas P Adams | Director | Edison, NJ |
| John P Cavan | Executive Officer | Edison, NJ |
| John P Brancaccio | Director | New Hope, PA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-08-05 | D | $3.1M | $3.1M |
| 2026-04-22 | D | $700K | $700K |
| 2024-07-24 | D | $2.9M | $2.9M |
| 2023-10-03 | D | $5.0M | $5.0M |
| 2022-11-15 | D | $20.0M | $20.0M |
| 2019-03-27 | D | $1.3M | $1.3M |
| 2014-10-23 | D | $12.5M | $9.0M |
| 2014-08-22 | D | $4.7M | $4.7M |